Calliditas Therapeutics Stock Forum

$Calliditas Therapeutics(CALT.US)$
NEWS
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
Consistent improvement in estimated glomerular filtrate rate (eGFR) with Nefecon treatment compared to placebo.
30% reduction in UPCR with Nefecon sustained over 2 years, leading to lower risk of kidney failure.
Significantly delayed time to kidney function decline events with Nefecon c...

$Calliditas Therapeutics(CALT.US)$ Get some volume going!

$Calliditas Therapeutics(CALT.US)$ price target of 40,85$Super Micro Computer(SMCI.US)$tipranks.com/ne...

$Calliditas Therapeutics(CALT.US)$
📊⚡️📊

$Calliditas Therapeutics(CALT.US)$ Now thats a Full FDA approval pop! Hehehe

$Calliditas Therapeutics(CALT.US)$ Calliditas Therapeutics Shares Are Trading Higher After the Company Announced FDA Approval of TARPEYO

Last week’s PDUFAs:
$Arcutis Biotherapeutics(ARQT.US)$ : Approved 12/15
• ZORYVE® (Roflumilast foam 0.3%)
⇒ topical foam
⇒ PDUFA: 12/16/23
⇒ NDA
⇒ Seborrheic dermatitis
$Merck & Co(MRK.US)$ : Approved 12/15
• KEYTRUDA (pembrolizumab) + Padcev (enfortumab vedotin-ejfv)
⇒ IV injection
⇒ PDUFA: 05/09/24
⇒ sBLA
⇒ Urothelial cancer
$Glaukos(GKOS.US)$ : Approved 12/14
• iDose® TR (travoprost)
⇒ intracameral implant
⇒ PDUFA: 12/22/23
⇒ NDA
⇒ Glaucoma
$Merck & Co(MRK.US)$ : Approved ...